[go: up one dir, main page]

DE60304678D1 - Idraparinux (sanorg 34006) zur behandlung und sekundärprophylaxe von thromboembolien bei patienten mit tiefer venenthrombose - Google Patents

Idraparinux (sanorg 34006) zur behandlung und sekundärprophylaxe von thromboembolien bei patienten mit tiefer venenthrombose

Info

Publication number
DE60304678D1
DE60304678D1 DE60304678T DE60304678T DE60304678D1 DE 60304678 D1 DE60304678 D1 DE 60304678D1 DE 60304678 T DE60304678 T DE 60304678T DE 60304678 T DE60304678 T DE 60304678T DE 60304678 D1 DE60304678 D1 DE 60304678D1
Authority
DE
Germany
Prior art keywords
venentrombosis
thromboembolients
sanorg
idraparinux
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60304678T
Other languages
English (en)
Other versions
DE60304678T2 (de
Inventor
Amsterdam Ronald Gijsbertu Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Application granted granted Critical
Publication of DE60304678D1 publication Critical patent/DE60304678D1/de
Publication of DE60304678T2 publication Critical patent/DE60304678T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE60304678T 2002-01-29 2003-01-23 Idraparinux (sanorg 34006) zur behandlung und sekundärprophylaxe von thromboembolien bei patienten mit tiefer venenthrombose Expired - Lifetime DE60304678T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02075374 2002-01-29
EP02075374 2002-01-29
PCT/EP2003/000696 WO2003063881A1 (en) 2002-01-29 2003-01-23 Idraparinux(sanorg 34006)for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis

Publications (2)

Publication Number Publication Date
DE60304678D1 true DE60304678D1 (de) 2006-05-24
DE60304678T2 DE60304678T2 (de) 2007-04-05

Family

ID=27635850

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60304678T Expired - Lifetime DE60304678T2 (de) 2002-01-29 2003-01-23 Idraparinux (sanorg 34006) zur behandlung und sekundärprophylaxe von thromboembolien bei patienten mit tiefer venenthrombose

Country Status (22)

Country Link
US (1) US7709463B2 (de)
EP (1) EP1471924B1 (de)
JP (1) JP4870907B2 (de)
CN (1) CN1622813A (de)
AR (1) AR038320A1 (de)
AT (1) ATE323497T1 (de)
AU (1) AU2003205664B2 (de)
BR (1) BR0307196A (de)
CA (1) CA2472957C (de)
CY (1) CY1107661T1 (de)
DE (1) DE60304678T2 (de)
DK (1) DK1471924T3 (de)
EA (1) EA007204B1 (de)
ES (1) ES2262971T3 (de)
MX (1) MXPA04007310A (de)
NO (1) NO332699B1 (de)
PE (1) PE20030855A1 (de)
PL (1) PL207144B1 (de)
PT (1) PT1471924E (de)
SI (1) SI1471924T1 (de)
TW (1) TWI281861B (de)
WO (1) WO2003063881A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR052419A1 (es) * 2004-12-01 2007-03-21 Osi Pharm Inc Derivados de bencimidazolil n-sustituidos,inhibidores del protooncogen c-kit
WO2012166611A2 (en) 2011-05-27 2012-12-06 Immune Disease Institute, Inc. Methods for treating and preventing neutrophil-derived net toxicity and thrombosis
MX2022000343A (es) 2019-07-09 2022-03-11 Optimvia Llc Metodos para sintetizar polisacaridos anticoagulantes.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type

Also Published As

Publication number Publication date
NO20043195L (no) 2004-10-29
DK1471924T3 (da) 2006-08-21
EP1471924B1 (de) 2006-04-19
PT1471924E (pt) 2006-09-29
DE60304678T2 (de) 2007-04-05
US7709463B2 (en) 2010-05-04
CA2472957A1 (en) 2003-08-07
MXPA04007310A (es) 2004-10-29
HK1072361A1 (en) 2005-08-26
EA200400817A1 (ru) 2005-02-24
WO2003063881A1 (en) 2003-08-07
PE20030855A1 (es) 2003-10-11
BR0307196A (pt) 2004-11-03
AR038320A1 (es) 2005-01-12
US20050209175A1 (en) 2005-09-22
SI1471924T1 (sl) 2006-10-31
PL207144B1 (pl) 2010-11-30
TWI281861B (en) 2007-06-01
AU2003205664B2 (en) 2008-06-05
CN1622813A (zh) 2005-06-01
EA007204B1 (ru) 2006-08-25
TW200302104A (en) 2003-08-01
JP2005519919A (ja) 2005-07-07
ES2262971T3 (es) 2006-12-01
PL370557A1 (en) 2005-05-30
NO332699B1 (no) 2012-12-10
CA2472957C (en) 2011-09-13
EP1471924A1 (de) 2004-11-03
ATE323497T1 (de) 2006-05-15
JP4870907B2 (ja) 2012-02-08
CY1107661T1 (el) 2013-04-18

Similar Documents

Publication Publication Date Title
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
DE60108080D1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
EP1438054A4 (de) Verfahren und zusammensetzungen zur behandlung von flaviviren und pestiviren mit 4'-modifiziertem nucleosid
DE60327622D1 (de) Kombinierte antitachykardie - schrittmacher und hochspannungstherapie zur behandlung von ventrikulären arrhythmien
ATE389649T1 (de) Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen
DE60221627D1 (de) Thiazolderivate und ihre Verwendung zur Behandlung oder Vorbeugung von Infektionen durch Flaviviren
DE60217136D1 (de) Benzothiazepin und benzothiadiazepin derivative mit hemmender wirkung auf den säuretransport in den gallengängen zur behandlung von hyperlipidaemia
DE50212701D1 (de) Bestrahlungsanordnung zur behandlung von akne und aknenarben
EP1392292A4 (de) Pyranoindazole und ihre verwendung in der glaukombehandlung
DE60233265D1 (de) 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten
DE602004010708D1 (de) Imidazopyridinsubstituierte tropanderivate mit ccr5-rezeptorantagonistischer wirkung zur behandlung von hiv und entzündungen
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE50205814D1 (de) Verwendung von mittelkettigen Triglyceriden zur Prävention und Therapie von Adipositas
DE60224004D1 (de) Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten
DE60233740D1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
EE200400074A (et) Koostised ning nende kasutamine proliferatiivsetehaiguste raviks
DE60125212D1 (de) Verwendung von Aivlosin zur Behandlung und Prevention der Lawsonia-Infektionen in Schweinen.
PL375564A1 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
DE60213234D1 (de) 4-(penylpiperidin-4-ylidenmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen, angstzuständen oder erkrankungen des magen-darm-trakts
DE60203878D1 (de) Verfahren zur vorbeugung gegen und behandlung von unterleibsschmerzen und magen-darmerkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition